Test Now Offered for Common Breast Cancer Gene
The Washington Post reports that a biotech company today will begin offering the first genetic test to assess a woman's risk for the most common forms of breast cancer. Prior to this, the only tests were for rare genes.
The company is Decode Genetics of Reykjavik, Iceland. This test will be performed using a simple blood sample or cheek swab.
This test costs $1,625. There has been much criticism of this test. Some said that the results could scare them unnecessarily. Others say that it could cause women not to get mammograms or other screening tests for breast cancer.
The Food and Drug Administration does not regulate such tests when they are performed by the labs offering them.
For more information about breast cancer, see the Pennsylvania breast cancer malpractice lawyers.